Updated EUCAST Clinical Breakpoints against <i>Aspergillus</i>, Implications for the Clinical Microbiology Laboratory
Azole resistance poses a problem for the management of patients with invasive aspergillosis. Former species are in fact groups of closely related species (or complexes); cryptic species frequently show high antifungal resistance. The European Committee on Antimicrobial Susceptibility Testing (EUCAST...
Main Author: | Jesús Guinea |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Journal of Fungi |
Subjects: | |
Online Access: | https://www.mdpi.com/2309-608X/6/4/343 |
Similar Items
-
A Pragmatic Approach to Susceptibility Classification of Yeasts without EUCAST Clinical Breakpoints
by: Karen Marie Thyssen Astvad, et al.
Published: (2022-01-01) -
Comparison of the Micronaut-AM System and the EUCAST Broth Microdilution Reference Method for MIC Determination of Four Antifungals against <i>Aspergillus fumigatus</i>
by: Nikolett Gyurtane Szabo, et al.
Published: (2023-06-01) -
In Vitro Activity of Ibrexafungerp against a Collection of Clinical Isolates of <i>Aspergillus</i>, Including Cryptic Species and Cyp51A Mutants, Using EUCAST and CLSI Methodologies
by: Olga Rivero-Menendez, et al.
Published: (2021-03-01) -
Usefulness of Microscan System panels with EUCAST clinical breakpoints to evaluate the antimicrobial susceptibility of ß-lactamase producing- Gram negative isolates
by: Elisabetta Nucleo, et al.
Published: (2011-12-01) -
EUCAST v.12.0 Review Focused on Changes
by: Sae Am Song
Published: (2022-09-01)